AVIR
Atea Pharmaceuticals Inc
NASDAQ: AVIR · HEALTHCARE · BIOTECHNOLOGY
$5.51
+1.47% today
Updated 2026-04-30
Market cap
$435.81M
P/E ratio
—
P/S ratio
1.55x
EPS (TTM)
$-1.94
Dividend yield
—
52W range
$2 – $6
Volume
0.5M
Atea Pharmaceuticals Inc (AVIR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-44.30%
ROA
-28.70%
Debt/equity
0.00x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $0.00 | $-9.06M | — | — | — |
| 2019 | $0.00 | $-13.46M | — | — | — |
| 2020 | $48.63M | $-10.95M | 21.82% | -22.68% | -22.51% |
| 2021 | $351.37M | $121.19M | 100.00% | 39.38% | 34.49% |
| 2022 | $192.18M | $-115.91M | -0.14% | -67.98% | -60.31% |
| 2023 | $0.00 | $-135.96M | — | — | — |
| 2024 | $0.00 | $-168.38M | — | — | — |
| 2025 | $0.00 | $-158.35M | — | — | — |